Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Cash from Financing Activities (2018 - 2025)

Exagen's Cash from Financing Activities history spans 8 years, with the latest figure at -$384000.0 for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 77.78% year-over-year to -$384000.0; the TTM value through Dec 2025 reached $24.4 million, up 3785.52%, while the annual FY2025 figure was $24.4 million, 3785.52% up from the prior year.
  • Cash from Financing Activities reached -$384000.0 in Q4 2025 per XGN's latest filing, down from $2.9 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $65.1 million in Q1 2021 to a low of -$10.2 million in Q2 2023.
  • Average Cash from Financing Activities over 5 years is $3.9 million, with a median of -$114500.0 recorded in 2023.
  • Peak YoY movement for Cash from Financing Activities: surged 127709.8% in 2021, then plummeted 3779.55% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at -$213000.0 in 2021, then grew by 18.78% to -$173000.0 in 2022, then fell by 27.17% to -$220000.0 in 2023, then grew by 1.82% to -$216000.0 in 2024, then crashed by 77.78% to -$384000.0 in 2025.
  • Per Business Quant, the three most recent readings for XGN's Cash from Financing Activities are -$384000.0 (Q4 2025), $2.9 million (Q3 2025), and $21.9 million (Q2 2025).